Purchase Order 75N92019P00359

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a delivery order to Illumina, Inc. on July 14, 2020, with a ceiling value of $248,412.08 for sequencing reagent kits for an Illumina NovaSeq 6000 sequencer to support the institute's core facility sequencing operations.</p> <p>Place of performance is San Diego, CA 92122. The order is priced on a firm fixed-price basis and has an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for a NovaSeq 6000 Sequencing System valued at $902,700 on August 27, 2019. Work is performed in San Diego, California. The order is firm fixed price with no set-aside designation. Ultimate completion is scheduled for April 10, 2020. The solicitation was posted August 7, 2019, with a due date of August 14, 2019.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a $93,450.56 delivery order to Illumina, Inc. on February 12, 2018, for customized HiSeq sequencing kits supporting genomic laboratories.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside and an ultimate completion date of September 2, 2020.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a delivery order to Illumina, Inc. on November 9, 2017, for custom sequencing services with a ceiling value of $15,802.66.</p> <p>Place of performance is San Diego, CA 92122. The order was completed by September 2, 2020. The work is priced on a firm fixed-price basis with no set-aside designation.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, awarded a $999,999.00 firm fixed price purchase order to Illumina, Inc. to provide a NovaSeq X Plus sequencing system. This award is based on a September 2023 solicitation from the National Heart Lung and Blood Institute seeking a high-throughput DNA sequencing platform to support genomic research. The contract has no set-aside designation and a...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a delivery order to Illumina, Inc. on August 16, 2017, for TrueSeq reagents and sequencing kits with a ceiling value of $27,044.29.</p> <p>Place of performance is San Diego, CA 92122. The order was firm fixed price with no set-aside. Ultimate completion date was September 2, 2020.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a $246,455.66 delivery order to Illumina, Inc. on September 17, 2019, for genetic sequencing and genomic analysis technologies. The order was firm fixed-price with no set-aside designation and an ultimate completion date of September 2, 2020. Place of performance is Bethesda, MD.</p>

<p>The National Institutes of Health National Human Genome Research Institute (NIH NHGRI) awarded a $999,999 firm fixed price purchase order to Illumina, Inc. of San Diego, California for a NOVASEQ X PLUS SEQUENCING SYSTEM. The sequencing system will be delivered to the prime contractor's location in San Diego between June 22, 2023 and September 29, 2023 to support the NIH NHGRI's genomic research efforts.</p>

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 2000 sequencers. The $202,227.89 award has a completion date of September 2, 2025 and does not utilize any set-aside designations....

The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $75,014.08 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide sequencing reagent kits for the agency's Illumina NovaSeq X Plus, NovaSeq 6000, and NextSeq 2000 sequencers to support its research efforts. No subcontractors or set aside designations were indicated. This...